The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Abstract
Objective. —To determine the relationship of brain infarction to the clinical expression of Alzheimer disease (AD). Design. —Cognitive function and the prevalence of dementia were determined for participants in the Nun Study who later died. At autopsy, lacunar and larger brain infarcts were identified, and senile plaques and neurofibrillary tangles in the neocortex were quantitated. Participants with abundant senile plaques and some neurofibrillary tangles in the neocortex were classified as having met the neuropathologic criteria for AD. Setting. —Convents in the Midwestern, Eastern, and Southern United States. Participants. —A total of 102 college-educated women aged 76 to 100 years. Main Outcome Measures. —Cognitive function assessed by standard tests and dementia and AD assessed by clinical and neuropathologic criteria. Results. —Among 61 participants who met the neuropathologic criteria for AD, those with brain infarcts had poorer cognitive function and a higher prevalence of dementia than those without infarcts. Participants with lacunar infarcts in the basal ganglia, thalamus, or deep white matter had an especially high prevalence of dementia, compared with those without infarcts (the odds ratio [OR] for dementia was 20.7,95% confidence interval [95% CI], 1.5-288.0). Fewer neuropathologic lesions of AD appeared to result in dementia in those with lacunar infarcts in the basal ganglia, thalamus, or deep white matter than in those without infarcts. In contrast, among 41 participants who did not meet the neuropathologic criteria for AD, brain infarcts were only weakly associated with poor cognitive function and dementia. Among all 102 participants, atherosclerosis of the circle of Willis was strongly associated with lacunar and large brain infarcts. Conclusion. —These findings suggest that cerebrovascular disease may play an important role in determining the presence and severity of the clinical symptoms of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Population-autopsy series verified the high frequency and pathogenetic importance of combined Alzheimer disease and vascular disease in the expression of dementia as mentioned previously.”
In the citing paper
“Furthermore, vascular lesions can lower the threshold for the clinical manifestation of Alzheimer disease.”
In the citing paper
“Several studies have found that in patients with Alzheimer disease and cerebrovascular disease, less Alzheimer disease pathology is needed to express the dementia syndrome.”
In the citing paper
“typically are accompanied by Alzheimer disease and other pathologies.”
In the citing paper
“Infarcts frequently coexist with Alzheimer disease pathology in the brains of older people.”
In the citing paper
“One study showed that only people with Alzheimer disease pathology with subcortical infarcts had dementia, raising the possibility of an interaction (a multiplicative effect) between the 2 pathologies.”
In the citing paper
“It is now accepted that many of the traditional risk factors for stroke are also risk markers for Alzheimer disease and VCI.16,31,340,484–491”
In the citing paper
“Lacunes are frequently seen on imaging in elderly patients with no symptoms”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [25]
In the citing paper
“are associated with an increased risk of stroke, gait impairment, and dementia.”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [25]
In the citing paper
“Cerebrovascular effects of APOE4 are associated with AD, stroke, and brain hemorrhage (314, 506, 549, 614, 693).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [549]
In the citing paper
“Classical anatomic locations for strategic infarcts include the thalamus, angular gyrus, and basal ganglia, including the caudate nucleus and globus pallidus. 52-57”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“A single small infarct may cause severe cognitive deficits when located in a strategic brain region.”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“However, vascular brain lesions lower the threshold of AD pathology required to induce dementia. 56,100-102”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“Earlier studies have suggested a multiplicative effect between vascular and AD-type pathology on cognitive decline, 56 whereas recent studies indicate that the effects are additive. 49,100,105”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“many older individuals with dementia suffer from a combination of vascular and Alzheimer-type pathology with an additive effect on cognition,19”
From Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement (2014) · cites this paper as [19]
In the citing paper
“On the other hand, in older individuals with moderate AD pathology subcortical vascular lesions are a major determinant of the expression of the dementia (Esiri et al., 1999; Schneider et al., 2007b; Snowdon et al., 1997).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Snowdon et al., 1997
In the citing paper
“it seems reasonable to postulate that insulin resistance and T2D could increase AD risk through cerebrovascular disease, a factor increasingly accepted to be important in AD manifestation [5, 19-21].”
From Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial (2016) · cites this paper as [5]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 1,401–1,500 of 1,644
Treatment Approaches for Alzheimer’s Disease
Gold, M., Felsenstein, K. M., & Molinoff, P. B. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-006-3_6 · Cited by 2
Gil‐Gregorio, P., Regidor‐García, J., Arriola‐Manchola, E., García‐Navarro, J. A., & Cantera, I. R. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01265.x · Cited by 2
Vascular factors in Alzheimer’s disease
Kivipelto, M., Solomon, A., & Ngandu, T. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511575976.015 · Cited by 2
Joray, S., Ghika, J. A., & Bogousslavsky, J. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(08)93032-3 · Cited by 2
Semplicini, A. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12584 · Cited by 2
Vitamin E and Memory: Is It Vascular Protection?
Miller, J. W. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2000.tb07540.x · Cited by 2
Troubles cognitifs et principales « démences » ou maladies dégénératives non Alzheimer
Rigaud, A., Duron, E., Seux, M., & Hugonot-Diener, L. (2010) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/s0246-1072(10)16949-1 · Cited by 2
Small vessel cerebrovascular disease in older adults
Slavin, H., McManus, J., & Stott, D. J. (2012) · Reviews in Clinical Gerontology · doi:10.1017/s0959259812000056 · Cited by 3
Quantitative effects of nefiracetam on spatial learning of rats after cerebral embolism
Le, D. T., Shin, C., Jackson-Friedman, C., & Lyden, P. D. (2001) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1053/jscd.2001.25454 · Cited by 2
Hypertension artérielle et démences
Hanon, O. (2014) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2014.05.011 · Cited by 2
Averting Dementia of the Alzheimer's Type in Women: Can Counselors Help?
Douthit, K. Z. (2007) · Adultspan Journal · doi:10.1002/j.2161-0029.2007.tb00026.x · Cited by 3
Casolla, B., & Leys, D. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107239340.016 · Cited by 2
Czapiewski, S., & Brown-Nyseth, V. (2016) · Springer eBooks · doi:10.1007/978-1-4939-2528-5_2 · Cited by 2
Origin(s) of Intraneuronal Amyloid
D’Andrea, M. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804256-4.00002-4 · Cited by 2
Microbleeds in relation to specific populations, diseases and neurological symptoms
Werring, D. J. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511974892.012 · Cited by 2
Is vascular cognitive impairment more common in Asia?
Lam, B. Y. K., & Mok, V. (2017) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2017.03.043 · Cited by 2
Brainin, M., & Heiss, W. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107239340.010 · Cited by 2
Health and Daily Functioning of Older Women Religious
Petrinec, A. B., Crowe, M. L., Flanagan, K., & Baker, J. R. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15984 · Cited by 2
Risk Factors for Aphasia in Cerebral Small Vessel Diseases
Xin, J., Huang, X., Pan, X., Lin, L., Sun, M., Liu, C., & Ye, Q. (2019) · Current Neurovascular Research · doi:10.2174/1567202616666190227202638 · Cited by 2
Dickie, D. A., Quinn, T. J., & Dawson, J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-31904-5_3 · Cited by 3
Budson, A. E., & Solomon, P. R. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-3597-8.00003-2 · Cited by 2
Homocysteine Determinants as Risk Markers for Neurological Diseases
Ojha, R. P., Dubey, G. P., Mishra, V. N., Jain, D., Dubey, S., Dubey, R., & Kesharwani, R. K. (2022) · Springer eBooks · doi:10.1007/978-981-16-6867-8_11 · Cited by 2
Introduction to Alzheimer’s Disease
Manivasagam, T., Surya, R., Jayalakshmi, M., Thenmozhi, A. J., Prema, A., Qoronfleh, M. W., Alharbi, H. F., & Rajamani, Y. (2023) · Nutritional neurosciences · doi:10.1007/978-981-99-0677-2_1 · Cited by 2
Association Between Syncope and Cognitive Impairment
Collins, O., & Kenny, R. A. (2011) · Aging Health · doi:10.2217/ahe.11.1 · Cited by 2
De quoi l’empathie déconcertante de la démence est-elle le nom ?
Hazif‐Thomas, C., Chandès, G., & Thomas, P. (2020) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/j.npg.2020.04.009 · Cited by 2
Cognitive and emotional impairment in patients with chronic cerebrovascular insufficiency
Bogolepova, A. N. (2020) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2020-8-27-35 · Cited by 2
Khouzam, H. R. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-04088-4.50023-4 · Cited by 2
Easing the burden of Alzheimer's disease: therapeutic options
Baumel, B. S. (1998) · European Journal of Neurology · doi:10.1111/j.1468-1331.1998.tb00445.x · Cited by 2
Drug Therapy for Dementia—Affecting More Than Just the Mind
Hardesty, J. L. (2006) · Topics in Geriatric Rehabilitation · doi:10.1097/00013614-200607000-00006 · Cited by 2
Hypertension artérielle et cerveau
Leys, D., Parnetti, L., & Pasquier, F. (1999) · Cited by 2
Paradise, M. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.05.010 · Cited by 2
Environmental enrichment in cognitive and brain aging
Smith, A. E., Bower, I. S., Fabiani, M., & Karayanidis, F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-820480-1.00050-4 · Cited by 2
Major or Mild Vascular Neurocognitive Disorder
Espiritu, A. I., Balakrishnar, K., Moradizadeh, M., Marlatt, N. E., & Burhan, A. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-47802-4_21 · Cited by 1
Wu, Y., Gong, S., Fei, L., & Yin, J. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1596812 · Cited by 1
Co-Morbid Disease as Risk Factors Associated with Alzheimer’s Disease- An Overview
Tyagi, A., Shekhar, N., & Tyagi, S. (2025) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-025-00307-z · Cited by 1
RETRACTED: Idea Density and Grammatical Complexity as Neurocognitive Markers
Iacono, D., & Feltis, G. C. (2025) · Brain Sciences · doi:10.3390/brainsci15091022 · Cited by 3
RetractedJain, A. K., Gozum, N., Subah, G., Malhotra, A., Garrett, J., Fortunato, M. P., Xu, P., Lin, D., Lui, A., Zebrowitz, E., et al. (2025) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2025.111728 · Cited by 1
Ururahy, R. D. R., Justo, A. F. O., Leite, R. E. P., Paes, V. R., Conforto, A. B., Grinberg, L. T., Pasqualucci, C. A., Ferriolli, E., & Suemoto, C. K. (2026) · Stroke · doi:10.1161/strokeaha.125.053151 · Cited by 2
Moran, K. L., Smith, C. J., Montaldi, D., & Muhlert, N. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106687 · Cited by 1
Wallraven, T., Günthner, R., Ribeiro, A., Alnemer, M. S., Kotliar, K. E., Lech, M., Bleidißel, N., Wicklein, R., Hauser, C., Streese, L., et al. (2026) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2026.101472 · Cited by 1
Mukri, G., Nandimandalam, H., Mondal, S., Bhat, J. S., Prabha, C., Gowtham, K. V., Shilpa, K., Singh, C., & Gadag, R. N. (2026) · Plant Breeding · doi:10.1111/pbr.70095 · Cited by 1
Hong, H., Chen, Y., Huang, P., & Markus, H. S. (2026) · International Journal of Stroke · doi:10.1177/17474930261475465 · Cited by 2
Oxidative stress and inflammation in neurodegenerative disorders
Jomová, K., Alomar, S. Y., Valko, R., Nepovimová, E., Kuča, K., & Valko, M. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04518-5 · Cited by 1
Chapter 15 Advances in Neuroimaging
Scheltens, P. (2007) · Blue books of neurology · doi:10.1016/s1877-184x(09)70066-8 · Cited by 1
Calcium Channel Blockers and Stroke Prevention
Poggesi, A., & Inzitari, D. (2012) · Springer eBooks · doi:10.1007/978-1-4419-9663-3_4 · Cited by 1
Tv, S., Kir'ianov, S. A., Коровайцева, Г. И., Селезнева, Н. Д., Voskresenskaya, N. I., Голимбет, В. Е., Farrer, L. A., Si, G., & Rogaev, E. I. (2001) · Neuroscience and Behavioral Physiology · doi:10.1023/a:1005264324466 · Cited by 1
Hyperhomocysteinemia and cardiovascular aging
Cattaneo, M., & Lussana, F. (2002) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(02)11035-2 · Cited by 1
Chapter 11 Vascular Cognitive Impairment
Erkinjuntti, T., & Kalaria, R. N. (2007) · Blue books of neurology · doi:10.1016/s1877-184x(09)70062-0 · Cited by 1
Heart failure: palliative care and changes in cognition
Nazarko, L. (2011) · British Journal of Healthcare Assistants · doi:10.12968/bjha.2011.5.2.70 · Cited by 1
Mori, T., Tateishi, N., & Asano, T. (2004) · CRC Press eBooks · doi:10.1201/9781420039740.ch17 · Cited by 1
Vascular Dementia and Vascular Cognitive Decline
Seshadri, S. S. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5478-8.10017-x · Cited by 1
Cerebral microbleeds and Alzheimer'sdisease
Cordonnier, C., & van der Flier, W. M. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511974892.016 · Cited by 1
How Does Alzheimer’s Begin and Who Gets It?
de la Torre, J. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-34057-9_1 · Cited by 1
Biomarkers in vascular dementia
Wallin, A., & Pirttilä, T. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511575976.008 · Cited by 1
Pathophysiology of Subclinical Brain Damage in Hypertension: Large Artery Disease
Laurent, S., Gąsecki, D., Boutouyrie, P., & Narkiewicz, K. (2016) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-32074-8_6 · Cited by 1
Hatanaka, H., Hirose, D., Hirao, K., Shimizu, S., Kanetaka, H., & Hanyu, H. (2017) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12989 · Cited by 1
Semplicini, A. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13176 · Cited by 1
Major or Mild Vascular Neurocognitive Disorder
Burhan, A. M., Moradizadeh, M., & Marlatt, N. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-67555-8_21 · Cited by 1
Diagnosis (1): Cognitive Syndromes, Comorbidities, No Diagnosis, and Wrong Diagnosis
Larner, A. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-75259-4_8 · Cited by 1
The past, present, and future of neurosurgery’s role in stroke
Dempsey, R. J., & Bowman, K. (2020) · Journal of neurosurgery · doi:10.3171/2020.1.jns193043 · Cited by 1
Schliebs, R. (2013) · Springer eBooks · doi:10.1007/978-3-642-30574-0_51 · Cited by 1
Assessment in Acute Stroke Rehabilitation
Cuesta, G. M., & Gettings, L. (2019) · Clinical handbooks in neuropsychology · doi:10.1007/978-3-319-93497-6_32 · Cited by 1
Chapter 8. Dementia and Mild Neurocognitive Disorders
Wise, E. A., & Lyketsos, C. G. (2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375196.ds08 · Cited by 1
Morrison, J., Fearon, D. O., Fernandes, M. A., & Tyas, S. L. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220106 · Cited by 1
Current Perspectives of Nanotherapeutics for the Treatment of Alzheimer’s Disease
Mishra, S., Senthilkumar, D., & Yadav, V. K. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815256505124010010 · Cited by 1
Vandenberghe, R. R. (2009) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-8061-9_20 · Cited by 1
Yaffe, K. S., & Barnes, D. E. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511581410.009 · Cited by 1
Dementia: What is it All About?
Almeida, O. P. (2006) · The Neuroradiology Journal · doi:10.1177/197140090601900404 · Cited by 1
Blood pressure and neuropsychological test performance in healthy postmenopausal women
Alsumali, A., Mekary, R. A., Seeger, J. D., & Regestein, Q. R. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.03.007 · Cited by 1
Carlson, B. W., Duke, J. B., Jones, K. R., Carlson, J. R., Craft, M., Coleman-Jackson, R., & Hershey, L. A. (2018) · Research in Gerontological Nursing · doi:10.3928/19404921-20181003-01 · Cited by 1
Vaskuläre kognitive Beeinträchtigung und Demenz
Gattringer, T. (2020) · Springer Reference Medizin · doi:10.1007/978-3-662-60676-6_127 · Cited by 1
Alzheimer's disease, appeal to public health
Janoutová, J., Kovaľová, M., Ambrož, P., Machaczka, O., Zatloukalová, A., Němček, K., Mrázková, E., Košta, O., & Janout, V. (2019) · Psychiatrie pro praxi · doi:10.36290/psy.2019.032 · Cited by 1
Understanding the relationship between oxidative stress and cognition in the elderly
Perry, N., Martin, L., Rosenfeldt, F., Ou, R., Rowsell, R., & Stough, C. K. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820593-8.00006-9 · Cited by 1
Asterixis and dysarthria-clumsy hand originated of lacunar infarction: A series of six cases
Herdoíza, J. P. M., Bittencourt-Fraga, D., Vizcaíno, G., & Siteneski, A. (2022) · Revista Ecuatoriana de Neurologia · doi:10.46997/revecuatneurol30300087 · Cited by 1
Effect of Folic Acid Supplementation in Postmenopausal Women
Paradisi, G., Ianniello, F., Basile, F., Cesare, C. D., Quagliozzi, L., Donati, L., & Caruso, A. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-373-2_17 · Cited by 1
Mental Stimulation and Dementia
Verghese, J. (2012) · Wiley eBooks · doi:10.1002/9781119952930.ch76 · Cited by 1
Applications of cholinesterase inhibitors
Stewart, R. J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05286-7 · Cited by 1
Knopman, D. S. (2005) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2005.06.024 · Cited by 1
Lyketsos, C. G., & Lee, H. B. (2004) · The Journals of Gerontology Series A · doi:10.1093/gerona/59.2.m185 · Cited by 1
Vascular risk factors and lipoprotein(a) levels in the differential diagnosis of dementias
Zuliani, G., Blè, A., Munari, M. R., Palmieri, E., Donegà, P., Volpato, S., Bader, G., Rossin, P. L. F., & Fellin, R. (1998) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(98)80079-4 · Cited by 1
Antihypertensive treatment and cognitive function: another tempest in a P pot?
Semplicini, A., & Inverso, G. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328306a72d · Cited by 1
Vascular dementia: from concepts to clinical practice
Ceccaldi, M. P. (2006) · Psychogeriatrics · doi:10.1111/j.1479-8301.2006.00134.x · Cited by 1
Does Preventing Stroke Prevent All Kinds of Dementia?
Chakraborty, N. (2004) · Stroke · doi:10.1161/01.str.0000143727.34523.d8 · Cited by 1
Positron Emission Tomography in Alzheimer‘s Disease: Early Prediction and Differentiation
Mistur, R. L., Mosconi, L., Santi, S. D., Li, Y., Tsui, W., & de Leon, M. J. (2008) · Future Neurology · doi:10.2217/14796708.4.1.23 · Cited by 1
Commentary on “Vascular cognitive impairment: Today and tomorrow”
Markesbery, W. R. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.04.004 · Cited by 1
White Matter Microstructure in Brain Aging: Human and Animal Models
Lamar, M. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.10.008 · Cited by 1
Cerebrovascular Disease in Hypertension
Chapman, N., Anderson, C. S., & Chalmers, J. P. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3053-9.50039-1 · Cited by 1
Structural neuroimaging: defining the cerebral context for cognitive rehabilitation
Ramirez, J., Gao, F. Q., & Black, S. E. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9781316529898.011 · Cited by 2
Lamar, M., Wortzel, H. S., Libon, D. J., Wambach, D. M., Price, C. C., & Kumar, A. A. (2012) · Wiley eBooks · doi:10.1002/9781119968900.ch4 · Cited by 1
Valk, J., Barkhof, F., & Scheltens, P. (2002) · Springer eBooks · doi:10.1007/978-3-642-56269-3_6 · Cited by 1
Singh, S., Lacoursiere, S. G., Mehla, J., Nazari, M., Sutherland, R. J., McDonald, R. J., & Mohajerani, M. H. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.25.513783 · Cited by 1
Neuropsychiatric Aspects of Vascular Cognitive Impairment
Skoog, I. G. (2010) · Springer eBooks · doi:10.1007/978-4-431-53871-4_11 · Cited by 1
Lacunes in — the Knowledge of — Vascular Dementia
Martínez‐Lage, P., & Hachinski, V. (1999) · Springer eBooks · doi:10.1007/978-88-470-2149-5_5
Jones, R. W. (2000) · doi:10.1002/9780470698747.ch2
Cognitive decline and brain natriuretic peptide: How are they related?
Caplan, L. R. (2014) · Annals of Neurology · doi:10.1002/ana.24221
Pasquier, F., & Orgogozo, J. (2001) · Blue books of practical neurology · doi:10.1016/s1877-3419(09)70015-7
Dementia Treatment: Let the Evidence Lead us
Demaerschalk, B. M., Woodruff, B. K., & Caselli, R. J. (2007) · Wiley eBooks · doi:10.1002/9780470988350.ch19
Rockwood, K. J. (2010) · doi:10.1002/9780470669600.ch37
Progressive aphasia complicated by intracerebral bleeding
Léger, G. C. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511997433.013
Alzheimer's Disease: Risk Factors and Preventive Strategies
Tschanz, J. T., & Breitner, J. C. S. (2010) · doi:10.1002/9780470669600.ch47
Metadata
- Authors
- Snowdon, D. A.
- Corresponding author
- Snowdon, David A.
- ORCID
- Snowdon, David A.
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1997-03-12
- Volume
- 277
- Issue
- 10
- Pages
- 813
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4296588155
- Cited by
- 1,590
- References
- 0
- Citations by year
- 2026: 23 · 2025: 31 · 2024: 30 · 2023: 39 · 2022: 43 · 2021: 42 · 2020: 51 · 2019: 57 · 2018: 52 · 2017: 60 · 2016: 74 · 2015: 63 · 2014: 71 · 2013: 61 · 2012: 74
- FWCI
- 34.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- Funders
- National Institute on Aging (R01AG009862, P50AG005144, KO4AG00553)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, cerebral infarction, lacunar infarction, dementia, cognitive function, amyloid plaques, neurofibrillary tangles, cerebrovascular disease, atherosclerosis, circle of Willis, thalamic infarction, basal ganglia infarcts, older women, neuropathology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
